Clinical trial
Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors
NCT00006450 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00006450 |
|---|---|
| Title | Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors |
| Official title | Phase II Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Progressive or Recurrent CNS Malignancy |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain Tumor |
| Intervention type | Drug |
| Interventions | Phenylbutyrate |
| Enrollment | 120 |
| Start date | Nov 1, 2000 |
| Completion | Jul 1, 2002 |
| First posted | Nov 8, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: